Brand-only drugs like Restasis, Eliquis and Lyrica can cost well over $500 for a month’s supply, and without cheaper generic alternatives, patients are often forced to either shell out their life savings or give up essential medications. FDA initiatives to expedite the drug review process and prohibit manufacturers from holding market exclusivity for too long will hopefully bring many generics to the market soon. See More
Zubsolv Latest News
Get the latest updates on this drug from the GoodRx medical team
It’s that time again—the new lists of covered and excluded drugs on next year’s insurance plans are out, and it doesn’t look great. For many Americans with health insurance, more than 50 popular brand-name and generic drugs may no longer be covered starting in January 2016.
Express Scripts and Caremark, companies that handles pharmacy benefits for more than 200 million Americans, are removing about 20 – 30 drugs each from their national preferred formularies at the end of 2015. See More
Methadone is no longer the mainstay of treatment for addiction from heroin and other opiates like Dilaudid, Oxycontin and fentanyl. The past couple years have brought newer medications, giving us more weapons in the war against opiate addiction.
Many of you have heard about Suboxone (buprenorphine/naloxone) for the treatment of opioid addiction (see my previous blog: https://www.goodrx.com/blog/2012/07/30/know-about-suboxone). See More